Lista de obras -

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B

artículo científico publicado en 2013

A Prospective Blinded Comparison of Video Capsule Endoscopy Versus Computed Tomography Enterography in Potential Small Bowel Bleeding: Clinical Utility of Computed Tomography Enterography

artículo científico publicado en 2016

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

artículo científico publicado en 2014

Alanine aminotransferase course, serum hepatitis B virus DNA, and liver stiffness measurement for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B.

artículo científico publicado en 2016

Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study

artículo científico publicado en 2012

Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study

artículo científico publicado en 2017

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

article by Masatoshi Kudo et al published 29 September 2014 in Hepatology

Can we predict final outcome of internal medicine residents with in-training evaluation

artículo científico publicado el 1 de febrero de 2011

Characteristics and outcomes of acute upper gastrointestinal bleeding after therapeutic endoscopy in the elderly ⬇️

artículo científico publicado el 28 de agosto de 2011

Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population

scientific article published on 01 March 2009

Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis

artículo científico publicado en 2015

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

artículo científico

Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients

artículo científico publicado en 2014

Effect of botulinum toxin injection for achalasia in Thai patients

scientific article published on 01 November 2006

Efficacy and safety of elbasvir/grazoprevir in participants with HCV genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: final results from the randomized C-CORAL study

article

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study ⬇️

artículo científico publicado el 1 de julio de 2011

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial

artículo científico publicado en 2016

Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial

artículo científico publicado en 2017

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.

artículo científico publicado en 2010

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

artículo científico publicado en 2016

Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection.

artículo científico publicado en 2018

Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis

artículo científico publicado en 2010

Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis

artículo científico publicado en 2018

Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study

artículo científico publicado en 2017

Genetic polymorphism of low-density lipoprotein receptor did not affect treatment outcome of chronic hepatitis C genotype 3

artículo científico publicado el 1 de febrero de 2011

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study

artículo científico publicado en 2017

Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments

artículo científico publicado en 2016

Hepatitis C genotype 6: A concise review and response-guided therapy proposal

artículo científico publicado en 2013

Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area

artículo científico publicado en 2016

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients ⬇️

artículo científico publicado el 1 de julio de 2011

Killer cell immunoglobulin‐like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a ⬇️

artículo científico publicado el 13 de julio de 2011

Lamivudine for patients with chronic hepatitis B and advanced liver disease

artículo científico publicado en 2004

Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment

artículo científico publicado en 2006

Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients

artículo científico publicado en 2015

Management of hepatitis C virus infection in the Asia-Pacific region: an update

artículo científico publicado en 2016

Pathologically different features and fibrosis scores in chronic hepatitis C genotypes 3 and 1.

artículo científico publicado en 2007

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand

artículo científico publicado en 2009

Predictive factors for synchronous common bile duct stone in patients with symptomatic cholelithiasis

artículo científico publicado en 2004

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

artículo científico publicado en 2015

Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.

artículo científico publicado en 2013

Resource Utilization and Direct Medical Costs of Chronic Hepatitis C in Thailand: A Heavy but Manageable Economic Burden

artículo científico publicado en 2013

Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study.

artículo científico publicado en 2006

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.

artículo científico publicado en 2016

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients

artículo científico publicado en 2017

Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

artículo científico publicado en 2018

Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

artículo científico publicado en 2008

The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response

artículo científico publicado en 2016

Treatment of Chronic Hepatitis C in Special Populations

artículo científico publicado en 2015

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study

artículo científico publicado en 2016

Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study

artículo científico publicado en 2019

Yield, etiologies and outcomes of capsule endoscopy in Thai patients with obscure gastrointestinal bleeding

artículo científico publicado en 2013

Lista de obras de

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B

A Prospective Blinded Comparison of Video Capsule Endoscopy Versus Computed Tomography Enterography in Potential Small Bowel Bleeding: Clinical Utility of Computed Tomography Enterography

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

Alanine aminotransferase course, serum hepatitis B virus DNA, and liver stiffness measurement for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B.

Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study

Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Can we predict final outcome of internal medicine residents with in-training evaluation

Characteristics and outcomes of acute upper gastrointestinal bleeding after therapeutic endoscopy in the elderly ⬇️

Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population

Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients

Effect of botulinum toxin injection for achalasia in Thai patients

Efficacy and safety of elbasvir/grazoprevir in participants with HCV genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: final results from the randomized C-CORAL study

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study ⬇️

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial

Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection.

Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis

Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis

Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study

Genetic polymorphism of low-density lipoprotein receptor did not affect treatment outcome of chronic hepatitis C genotype 3

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study

Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments

Hepatitis C genotype 6: A concise review and response-guided therapy proposal

Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients ⬇️

Killer cell immunoglobulin‐like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a ⬇️

Lamivudine for patients with chronic hepatitis B and advanced liver disease

Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment

Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients

Management of hepatitis C virus infection in the Asia-Pacific region: an update

Pathologically different features and fibrosis scores in chronic hepatitis C genotypes 3 and 1.

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand

Predictive factors for synchronous common bile duct stone in patients with symptomatic cholelithiasis

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.

Resource Utilization and Direct Medical Costs of Chronic Hepatitis C in Thailand: A Heavy but Manageable Economic Burden

Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study.

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients

Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response

Treatment of Chronic Hepatitis C in Special Populations

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study

Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study

Yield, etiologies and outcomes of capsule endoscopy in Thai patients with obscure gastrointestinal bleeding